Insider Trading May 4, 2026 04:04 PM

Sanmina Executive Vice President Executes Stock Sale Amid Strong Fiscal Performance

Alan McWilliams liquidates $218,170 in common stock as Sanmina trades near yearly highs following significant earnings beat.

By Ajmal Hussain SANM
Sanmina Executive Vice President Executes Stock Sale Amid Strong Fiscal Performance
SANM

Alan McWilliams, the Executive Vice President of Global Human Resources at Sanmina Corp (NASDAQ: SANM), has completed a sale of company shares. The transaction, which took place on May 1, 2026, involved the disposal of 1,000 shares of common stock at a price of $218.17 per share, resulting in total proceeds of $218,170. This movement was officially documented through a Form 4 filing submitted to the Securities and Exchange Commission.Following this specific transaction, Mr. McWilliams maintains a direct ownership stake in Sanmina consisting of 31,481 shares. This sale occurs during a period where the company's stock has shown significant momentum, trading close to its 52-week high of $230.56 and having achieved a 178% return over the previous year. Currently, Sanmina is valued at $11.64 billion with a price-to-earnings (P/E) ratio of 46.33.

Key Points

  • Sanmina reported a significant earnings surprise in Q2 fiscal 2026, with EPS beating estimates by over 31%.
  • The stock has experienced massive growth, yielding a 178% return over the past year.
  • Insider selling occurred while the stock was trading near its 52-week high.

Sanmina Corp (NASDAQ: SANM) saw recent insider activity as Alan McWilliams, the company's Executive Vice President of Global Human Resources, executed a sale of common stock. According to regulatory filings with the Securities and Exchange Commission, Mr. McWilliams sold 1,000 shares on May 1, 2026. The transaction was finalized at a price point of $218.17 per share, totaling a cash value of $218,170.

Post-transaction data indicates that Mr. McWilliams continues to hold 31,481 shares of Sanmina common stock directly. The timing of this sale coincides with the stock's performance near its 52-week peak of $230.56. Over the last twelve months, the company has seen a substantial return of 178%.


Key Market Observations

The recent activity at Sanmina highlights several critical points regarding the company's current market standing:

  • Exceptional Stock Momentum: The company has demonstrated significant growth, with shares delivering a 178% return over the past year and currently trading near their annual high of $230.56.
  • Strong Financial Outperformance: In the second quarter of fiscal year 2026, Sanmina reported earnings per share (EPS) of $3.16, which surpassed analyst expectations of $2.40 by a margin of 31.67%. Additionally, revenue for the quarter hit $4.01 billion, exceeding forecasts by 21.88%.
  • Valuation Metrics: The company currently operates with a P/E ratio of 46.33 and holds an overall market valuation of $11.64 billion.

These factors suggest that Sanmina's recent financial success has bolstered investor sentiment and potentially influenced analyst outlooks.


Risks and Valuation Uncertainties

While the financial reports have been positive, certain data points present potential risks for investors in the manufacturing and technology sectors:

  • Overvaluation Concerns: Based on InvestingPro analysis, Sanmina's stock is currently positioned on a list of most overvalued stocks. The assessment suggests that the current trading price appears high relative to its estimated Fair Value.
  • High Valuation Multiples: With a P/E ratio of 46.33, the company's valuation metrics reflect high expectations which may impact market volatility if performance deviates from these levels.

Risks

  • The company is currently identified as being overvalued relative to its Fair Value according to InvestingPro analysis.
  • High P/E ratios and trading near 52-week highs can introduce valuation risks for the broader technology/manufacturing sector.

More from Insider Trading

Emergent BioSolutions Director Keith Katkin Executes Stock Sales and Receives New Equity Grants May 4, 2026 Emergent BioSolutions Director Executes Stock Sales Under Pre-Arranged Plan May 4, 2026 Emergent BioSolutions Director Executes Stock Sale Under Rule 10b5-1 Plan May 4, 2026 I Squared Capital-Linked Entities Liquidate $27 Million in Kinetik Holdings Stock May 4, 2026 Riskified Executive Assaf Feldman Executes Planned Share Sale May 4, 2026